HCC-Related LncRNAs: Roles and Mechanisms
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Hepatocellular carcinoma (HCC) presents a significant global health threat, particularly in regions endemic to hepatitis B and C viruses, and because of the ongoing pandemic of obesity causing metabolic-dysfunction-related fatty liver disease (MAFLD), a precursor to HCC. The molecular intricacies of HCC, genetic and epigenetic alterations, and dysregulated signaling pathways facilitate personalized treatment strategies based on molecular profiling. Epigenetic regulation, encompassing DNA methyltion, histone modifications, and noncoding RNAs, functions as a critical layer influencing HCC development. Long noncoding RNAs (lncRNAs) are spotlighted for their diverse roles in gene regulation and their potential as diagnostic and therapeutic tools in cancer. In this review, we explore the pivotal role of lncRNAs in HCC, including MAFLD and viral hepatitis, the most prevalent risk factors for hepatocarcinogenesis. The dysregulation of lncRNAs is implicated in HCC progression by modulating chromatin regulation and transcription, sponging miRNAs, and influencing structural functions. The ongoing studies on lncRNAs contribute to a deeper comprehension of HCC pathogenesis and offer promising routes for precision medicine, highlighting the utility of lncRNAs as early biomarkers, prognostic indicators, and therapeutic targets.
Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2025; 11():150-157.
PMID: 39829957 PMC: 11742574. DOI: 10.1016/j.ncrna.2024.12.002.
Zhu S, Wang G, Zhang Y, Zou M, Li Z, Qu S Transl Oncol. 2024; 52():102254.
PMID: 39721246 PMC: 11732567. DOI: 10.1016/j.tranon.2024.102254.
Samir A, Abdeldaim A, Mohammed A, Ali A, Alorabi M, Hussein M Sci Rep. 2024; 14(1):29582.
PMID: 39609501 PMC: 11604705. DOI: 10.1038/s41598-024-80926-w.
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma.
Tonon F, Grassi C, Tierno D, Biasin A, Grassi M, Grassi G Int J Mol Sci. 2024; 25(22).
PMID: 39596302 PMC: 11594412. DOI: 10.3390/ijms252212235.
Wan W, Pan Y, Pang J, Bai X, Li L, Kang T J Hepatocell Carcinoma. 2024; 11:1945-1959.
PMID: 39429915 PMC: 11488511. DOI: 10.2147/JHC.S476612.